Last $3.56 USD
Change Today +0.036 / 1.02%
Volume 4.8K
RVP On Other Exchanges
Symbol
Exchange
NYSE Amex
As of 8:04 PM 04/17/14 All times are local (Market data is delayed by at least 15 minutes).

retractable technologies inc (RVP) Key Developments

Retractable Technologies, Inc. Declares Dividends to Series I and II Class B Preferred Stock Shareholders, Payable on April 21, 2014

Retractable Technologies, Inc. announced that its Board of Directors has declared dividends to holders of its Series I Class B and Series II Class B Convertible Preferred Stock in the amounts of $12,937.50 and $44,675.00, respectively. The dividend amount is $0.125 per share for Series I Class B shareholders and $0.25 per share for Series II Class B shareholders. Dividends have accrued at 10% per annum and cover amounts in arrears from December 31, 2013 through date of conversion or March 31, 2014, whichever is applicable. The dividends will be paid on April 21, 2014 to shareholders of record as of the close of business on April 11, 2014.

Retractable Technologies, Inc. Declares Dividends to Series I and II Class B Preferred Stock Shareholders, Payable on January 20, 2014

Retractable Technologies, Inc. announced that its board of directors has declared dividends to holders of its Series I Class B and Series II Class B Convertible Preferred Stock in the amounts of $12,937.50 and $44,675.00, respectively. The dividend amount is $0.125 per share for Series I Class B shareholders and $0.25 per share for Series II Class B shareholders. Dividends have accrued at 10% per annum and cover amounts in arrears from September 30, 2013 through date of conversion or December 31, 2013, whichever is applicable. The dividends will be paid on January 20, 2014 to shareholders of record as of the close of business on January 10, 2014.

Retractable Technologies, Inc. Announces Earnings Results for the Third Quarter and Nine Months Ended September 30, 2013

Retractable Technologies, Inc. announced earnings results for the third quarter and nine months ended September 30, 2013. The company's domestic sales accounted for 80.2% and 75.8% of the revenues for the three months ended September 30, 2013 and 2012, respectively. Domestic revenues increased 2.7%. Domestic unit sales increased 8.3% principally due to increased sales volume of the 1mL syringe. Domestic unit sales were 72.3% of total unit sales for the three months ended September 30, 2013. International revenues decreased from $2.3 million in 2012 to $1.8 million in 2013, primarily due to lower 1mL syringe sales. Overall unit sales decreased 3.2%. Operating loss was $825,000 compared to an operating loss for the same period last year of $211,000 due primarily to higher operating costs and marginally lower gross profit. The company's domestic sales accounted for 76.8% and 77.9% of the revenues for the nine months ended September 30, 2013 and 2012, respectively. Domestic revenues decreased 10.5% principally due to lower 1mL syringe revenues. Domestic unit sales decreased 0.4%. Domestic unit sales were 66.9% of total unit sales for the nine months ended September 30, 2013. International revenues decreased from $5.7 million in 2012 to $5.4 million in 2013 primarily due to lower 5mL and 10mL syringe revenues mitigated by higher 1mL syringe revenues. Overall unit sales decreased 2.6%. Operating loss was $4.6 million compared to an operating loss for the same period last year of $1.4 million due primarily to lower gross profit and higher operating expenses. The company reported approximately $2.9 million in cash flow in the nine months ended September 30, 2013 was provided by operating activities.

Retractable Technologies, Inc. Declares Dividends to Series I and II Class B Preferred Stock Shareholders, payable on November 11, 2013

Retractable Technologies, Inc. announced that its Board of Directors has declared dividends to holders of its Series I Class B and Series II Class B Convertible Preferred Stock in the amounts of $12,937.50 and $44,675.00, respectively. The dividend amount is $0.125 per share for Series I Class B shareholders and $0.25 per share for Series II Class B shareholders. Dividends have accrued at 10% per annum and cover amounts in arrears from June 30, 2013 through date of conversion or September 30, 2013, whichever is applicable. The dividends will be paid on November 11, 2013 to shareholders of record as of the close of business on October 31, 2013.

Retractable Technologies, Inc. Reports Earnings Results for the Second Quarter and First Half Ended June 30, 2013

Retractable Technologies, Inc. reported earnings results for the second quarter and first half ended June 30, 2013. Domestic sales accounted for 69.0% and 77.9% of the revenues for the three months ended June 30, 2013 and 2012, respectively. Domestic revenues decreased 29.9% principally due to lower average selling prices and lower volumes. Domestic unit sales decreased 18.7% due to decreased sales of the 1mL syringe. Domestic unit sales were 55.6% of total unit sales for the three months ended June 30, 2013. International revenue and unit sales increased 10.8% and 15.6%, respectively, due to higher South American sales. Overall unit sales decreased 6.3%. Operating loss was $2.4 million compared to an operating loss for the same period last year of $532,000 due primarily to lower gross profit and higher operating expenses. Domestic sales accounted for 74.6% and 79.1% of the revenues for the six months ended June 30, 2013 and 2012, respectively. Domestic revenues decreased 17.8% principally due to decreased average sales prices and lower volumes. Domestic unit sales decreased 6.3% due to lower sales of the 1mL and 3mL syringes. Domestic unit sales were 63.0% of total unit sales for the six months ended June 30, 2013. International revenues and unit sales increased 6.0% and 5.9%, respectively due to higher South American sales. Overall unit sales decreased 2.1%. Operating loss was $3.8 million compared to an operating loss for the same period last year of $1.2 million due primarily to lower sales volumes and higher unit costs as well as increased operating expenses. Approximately $5.4 million in cash flow in the six months ended June 30, 2013 was used by operating activities.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
RVP:US $3.56 USD +0.036

RVP Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Becton Dickinson and Co $113.16 USD +0.23
Covidien PLC $69.86 USD +0.02
View Industry Companies
 

Industry Analysis

RVP

Industry Average

Valuation RVP Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 3.2x
Price/Book 3.5x
Price/Cash Flow NM Not Meaningful
TEV/Sales 2.2x
 | 

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact RETRACTABLE TECHNOLOGIES INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.